These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7526526)

  • 1. Transurethral resection of the prostate among Medicare beneficiaries in the United States: time trends and outcomes. Prostate Patient Outcomes Research Team (PORT).
    Lu-Yao GL; Barry MJ; Chang CH; Wasson JH; Wennberg JE
    Urology; 1994 Nov; 44(5):692-8; discussion 698-9. PubMed ID: 7526526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transurethral resection of the prostate among medicare beneficiaries: 1984 to 1997. For the Patient Outcomes Research Team for Prostatic Diseases.
    Wasson JH; Bubolz TA; Lu-Yao GL; Walker-Corkery E; Hammond CS; Barry MJ
    J Urol; 2000 Oct; 164(4):1212-5. PubMed ID: 10992368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(17):1-121. PubMed ID: 23074487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unequal use of new technologies by race: the use of new prostate surgeries (transurethral needle ablation, transurethral microwave therapy and laser) among elderly Medicare beneficiaries.
    Yu X; McBean AM; Caldwell DS
    J Urol; 2006 May; 175(5):1830-5; discussion 1835. PubMed ID: 16600772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in repeat prostatectomy after surgery for benign prostate disease: application of record linkage to healthcare outcomes.
    Semmens JB; Wisniewski ZS; Bass AJ; Holman CD; Rouse IL
    BJU Int; 1999 Dec; 84(9):972-5. PubMed ID: 10571622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia.
    Cowles RS; Kabalin JN; Childs S; Lepor H; Dixon C; Stein B; Zabbo A
    Urology; 1995 Aug; 46(2):155-60. PubMed ID: 7542818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety Evaluation of Transurethral Resection of the Prostate versus Plasmakinetic Enucleation of the Prostate in the Treatment of Massive Benign Prostatic Hyperplasia.
    Zhang J; Wang Y; Li S; Jin S; Zhang S; Zhao C; Yang W; Cui S; Liu Y
    Urol Int; 2021; 105(9-10):735-742. PubMed ID: 33524981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retreatment rates and postprocedural complications are higher than expected after BPH surgeries: a US healthcare claims and utilization study.
    Kaplan S; Kaufman RP; Mueller T; Elterman D; Chughtai B; Rukstalis D; Woo H; Roehrborn C
    Prostate Cancer Prostatic Dis; 2024 Sep; 27(3):485-491. PubMed ID: 37884615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thulium laser transurethral vaporesection versus transurethral resection of the prostate for benign prostatic obstruction: the UNBLOCS RCT.
    Worthington J; Lane JA; Taylor H; Young G; Noble SM; Abrams P; Ahern A; Brookes ST; Cotterill N; Johnson L; Khan R; Fernandez AM; Page T; Swami S; Hashim H
    Health Technol Assess; 2020 Sep; 24(41):1-96. PubMed ID: 32901611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized study of transurethral resection of the prostate and combined transurethral resection and vaporization of the prostate as a therapeutic alternative in men with benign prostatic hyperplasia.
    Küpeli S; Yilmaz E; Soygür T; Budak M
    J Endourol; 2001 Apr; 15(3):317-21. PubMed ID: 11339401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Hiraoka's Transurethral Detachment Prostatectomy and Transurethral Resection of the Prostate Effects on Postoperative Erectile Function in Patients With Benign Prostatic Hyperplasia: A Prospective Randomized Controlled Study.
    Pan C; Zhan Y; Zhao Y; Wu B; Bai S
    J Sex Med; 2020 Nov; 17(11):2181-2190. PubMed ID: 32665211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microwave thermotherapy for benign prostatic hyperplasia.
    Hoffman RM; Monga M; Elliott SP; Macdonald R; Langsjoen J; Tacklind J; Wilt TJ
    Cochrane Database Syst Rev; 2012 Sep; (9):CD004135. PubMed ID: 22972068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microwave thermotherapy for benign prostatic hyperplasia.
    Hoffman RM; Monga M; Elliot SP; Macdonald R; Wilt TJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD004135. PubMed ID: 17943811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of benign prostatic hyperplasia in the 21st century: temporal trends in Australian population-based data.
    Morton A; Williams M; Perera M; Teloken PE; Donato P; Ranasinghe S; Chung E; Bolton D; Yaxley J; Roberts MJ
    BJU Int; 2020 Sep; 126 Suppl 1():18-26. PubMed ID: 32558340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Effectiveness and Safety of Transvesical Open Prostatectomy versus Transurethral Resection of the Prostate in Patients with Benign Prostatic Hyperplasia with a Prostate Weight of 65-40 Gram.
    Sofimajidpour H; Khoshyar A; Zareie B; Sofimajidpour H; Rasouli MA
    Urol J; 2020 Nov; 18(3):289-294. PubMed ID: 33159313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.
    Schmid M; Meyer CP; Reznor G; Choueiri TK; Hanske J; Sammon JD; Abdollah F; Chun FK; Kibel AS; Tucker-Seeley RD; Kantoff PW; Lipsitz SR; Menon M; Nguyen PL; Trinh QD
    JAMA Oncol; 2016 Jan; 2(1):85-93. PubMed ID: 26502115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palliative transurethral prostate resection for bladder outlet obstruction in patients with locally advanced prostate cancer.
    Crain DS; Amling CL; Kane CJ
    J Urol; 2004 Feb; 171(2 Pt 1):668-71. PubMed ID: 14713783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SURGICAL MANAGEMENT OF BPH IN GHANA: A NEED TO IMPROVE ACCESS TO TRANSURETHRAL RESECTION OF THE PROSTATE.
    Kyei MY; Mensah JE; Morton B; Gepi-Attee S; Klufio GO; Yeboah ED
    East Afr Med J; 2012 Jul; 89(7):241-5. PubMed ID: 26845803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of prostate cancer and death after benign transurethral resection of the prostate-A 20-year population-based analysis.
    Hilscher M; Røder A; Helgstrand JT; Klemann N; Brasso K; Vickers AJ; Stroomberg HV
    Cancer; 2022 Oct; 128(20):3674-3680. PubMed ID: 35975979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased population use of medications for male lower urinary tract symptoms/benign prostatic hyperplasia correlates with changes in indications for transurethral resection of the prostate.
    Ingimarsson JP; Isaksson HJ; Sigbjarnarson HP; Gudmundsson J; Geirsson G
    Scand J Urol; 2014 Feb; 48(1):73-8. PubMed ID: 23924152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.